Showing results (161-170 of 240) with videos related to
Sort By:
Pageof 24
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 13, 2016
A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitisChie Miyabe, Yoshishige Miyabe, Takaki Komiya, et al.Journal of the American Society of Nephrology : JASN|March 14, 2008
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney diseaseJulia Menke, Geraldine C Zeller, Eriya Kikawada, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivoReza Abdi, Terry K Means, Toshiro Ito, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 1, 2013
Durable knockdown and protection from HIV transmission in humanized mice treated with gel-formulated CD4 aptamer-siRNA chimerasLee Adam Wheeler, Vladimir Vrbanac, Radiana Trifonova, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
The leukotriene B4 receptor (BLT1) is required for effector CD8+ T cell-mediated, mast cell-dependent airway hyperresponsivenessChristian Taube, Nobuaki Miyahara, Vanessa Ott, et al.Proceedings of the National Academy of Sciences of the United States of America|March 19, 2008
Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malariaGabriele S V Campanella, Andrew M Tager, Joseph K El Khoury, et al.Journal of Autoimmunity|August 12, 2023
Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokineSakari Pöysti, Satu Silojärvi, Thomas C Brodnicki, et al.Immunity|May 18, 2019
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 TherapyMelvyn T Chow, Aleksandra J Ozga, Rachel L Servis, et al.Arthritis and Rheumatism|February 10, 2011
Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of sclerodermaFlavia V Castelino, Jon Seiders, Gretchen Bain, et al.Plos One|December 8, 2015
Allergic Non-Asthmatic Adults Have Regional Pulmonary Responses to Segmental Allergen ChallengeVanessa J Kelly, Tilo Winkler, Jose G Venegas, et al.Pageof 24